Evidence map›Paper›PMID 29742714›Full record

ArticleMedicine2018

Rare ectopic metastasis from clear cell renal cell carcinoma to the chest wall after 10 years: A case report.

Chunyang Jiang, Shan Zhao, Bingjun Yang, Tao Tang, Ruipeng Hou, Xiaoqin Liu, Hui Zhao

Abstract readCase Reports
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunyang JiangDepartment of Thoracic Surgery, Tianjin Union Medical Center, Hongqiao District, Tianjin Department of Medical Oncology, The Second Hospital of Hebei Medical University, Xinhua District, Shijiazhuang Department of Pathology Department of Urology Surgery, Tianjin Union Medical Center, Hongqiao District, Tianjin Department of Nephrology, Hongqi Hospital, Mudanjiang Medical College, Aimin District, Mudanjiang, Heilongjiang, People's Republic of China.
Shan Zhao
Bingjun Yang
Tao Tang
Ruipeng Hou
Xiaoqin Liu
Hui Zhao

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleClear cell renal cell carcinoma (CCRCC) is an aggressive tumor associated with a high risk of metastasis and very low survival rate. In addition, it can cause extensive blood metastasis to the lungs, bones, and other organs. Chest wall metastatic tumors from primary CCRCC are rare. PATIENT CONCERNS: In this report, we present a case of metastatic chest wall tumor that originated from a CCRCC. DIAGNOSES: An 86-year-old man was diagnosed with chest wall tumor using chest computed tomography. After collecting tissues from the chest wall tumor via needle biopsy, the pathological examination was combined with positive immunoreaction of CD10, epithelial membrane antigen, and vimentin, and the patient was diagnosed with metastatic CCRCC in the chest wall deposits.

interventionsThe patient received radiotherapy at 2.0 Gy per time for 25 times. OUTCOMES: Following 2 months of treatment, the chest wall tumor had shrunk by about one-third of its size. LESSONS: Our patient developed a metastatic chest wall tumor that originated from a CCRCC for which right nephrectomy had been performed 10 years previously. Although as per the literature, chest wall metastasis from CCRCC is very rare, it is important to consider tumor metastasis after several years of treatment for precise diagnosis and proper treatment.

Indexed as

Aged, 80 and overCarcinoma, Renal CellHumansKidney NeoplasmsMaleNephrectomyThoracic NeoplasmsThoracic WallTime Factors

Identifiers

PMID29742714
PMCPMC5959438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.